0001235802-19-000141.txt : 20191223
0001235802-19-000141.hdr.sgml : 20191223
20191223161600
ACCESSION NUMBER: 0001235802-19-000141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191220
FILED AS OF DATE: 20191223
DATE AS OF CHANGE: 20191223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrews Julie
CENTRAL INDEX KEY: 0001550508
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35065
FILM NUMBER: 191306241
MAIL ADDRESS:
STREET 1: 5677 AIRLINE ROAD
CITY: ARLINGTON
STATE: TN
ZIP: 38002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Wright Medical Group N.V.
CENTRAL INDEX KEY: 0001492658
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 980509600
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1229
BUSINESS ADDRESS:
STREET 1: PRINS BERNHARDPLEIN 200
CITY: AMSTERDAM
STATE: P7
ZIP: 1097JB
BUSINESS PHONE: 901-867-4317
MAIL ADDRESS:
STREET 1: 1023 CHERRY ROAD
CITY: MEMPHIS
STATE: TN
ZIP: 38117
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier N.V.
DATE OF NAME CHANGE: 20110201
FORMER COMPANY:
FORMER CONFORMED NAME: Tornier B.V.
DATE OF NAME CHANGE: 20100524
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-12-20
0
0001492658
Wright Medical Group N.V.
WMGI
0001550508
Andrews Julie
1023 CHERRY ROAD
MEMPHIS
TN
38117
0
1
0
0
SVP, Global Finance
Ordinary Shares, par value EUR 0.03 per share
2019-12-20
4
M
0
9000
19.36
A
41715
D
Ordinary Shares, par value EUR 0.03 per share
2019-12-20
4
S
0
7001
30.0974
D
34714
D
Stock Option (right to buy)
19.36
2019-12-20
4
M
0
9000
0
D
2022-05-18
Ordinary Shares
9000
11618
D
Exercise and sale of vested stock options in connection with 280G tax planning under a pre-arranged sales instruction pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
Includes 1,368 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan. 4,777 ordinary shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. 2017 Equity and Incentive Plan and 3,951 shares that will be issued over time upon vesting pursuant to restricted stock units granted under the Wright Medical Group N.V. Amended and Restated 2017 Equity and Incentive Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.08 to $30.125, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
This option has fully vested.
/s/ Marija Nelson, attorney-in-fact
2019-12-23